PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension

Information

  • Research Project
  • 9463552
  • ApplicationId
    9463552
  • Core Project Number
    R01HL134673
  • Full Project Number
    5R01HL134673-02
  • Serial Number
    134673
  • FOA Number
    PA-13-302
  • Sub Project Id
  • Project Start Date
    4/1/2017 - 7 years ago
  • Project End Date
    1/31/2021 - 4 years ago
  • Program Officer Name
    XIAO, LEI
  • Budget Start Date
    2/1/2018 - 7 years ago
  • Budget End Date
    1/31/2019 - 6 years ago
  • Fiscal Year
    2018
  • Support Year
    02
  • Suffix
  • Award Notice Date
    1/23/2018 - 7 years ago

PHORA: A Clinical Decision Support Tool for Patients with Pulmonary Arterial Hypertension

ABSTRACT This application seeks to develop a multi-platform clinical decision support system (CDSS) in pulmonary arterial hypertension (PAH) for physicians, PHORA (Pulmonary Hypertension Outcomes Risk Assessment), which can be used to: (a) guide therapeutic decisions and (b) optimize clinical trial design. We will achieve this goal by utilizing clinical trial data from several large databases of completed trials in PAH, an ongoing PAH registry (REVEAL), as well as observational sessions with physicians. The proposed aims co- create the CDSS with a multi-disciplinary group of specialties including: biomedical engineering, advanced PAH physicians, computer science (machine learning/data mining), human computer interaction, and allied health care experts. Our intention is to engage all stakeholders to achieve consensus and thereby assure the acceptance of PHORA into practice. Successful completion of this project will lay the foundation for a prospective, multi-center trial in which PHORA will be evaluated with respect to long-term patient outcomes. The ultimate aim is to disseminate this resource so as to improve the efficiency, efficacy, and cost- effectiveness of this treatment for PAH.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
    571219
  • Indirect Cost Amount
    109445
  • Total Cost
    680664
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    838
  • Ed Inst. Type
  • Funding ICs
    NHLBI:680664\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    RIBT
  • Study Section Name
    Respiratory Integrative Biology and Translational Research Study Section
  • Organization Name
    ALLEGHENY-SINGER RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    033098401
  • Organization City
    PITTSBURGH
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    152124756
  • Organization District
    UNITED STATES